Skip to Main Content

Paper Details

Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.
Exp Hematol
41
2016
-ZNF384 gene fusion, B-ALL, EP300, ETV6, FLT3, FLT3 gene, IKZF1, NF1, PAX5, RB1, RNA, SETD2, ZNF384, cancers, custom, locus, patient, patients, relapse genome, relapsed adult B-lymphoblastic leukemia, stem cell, sunitinib, tumor, whole-exome, whole-genome, whole-transcriptome
Adult, Antineoplastic Combined Chemotherapy Protocols, Biopsy, Bone Marrow, Bone Marrow Transplantation, Cyclophosphamide, Cytogenetic Analysis, Dexamethasone, Doxorubicin, Flow Cytometry, Gene Expression Profiling, Genetic Variation, Genomics, Graft vs Host Disease, Humans, Male, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Recurrence, Transcriptional Activation, Transplantation, Homologous, Vincristine, fms-Like Tyrosine Kinase 3
Author NameAffiliation
Malachi GriffithMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
Obi L GriffithMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
Kilannin KrysiakMcDonnell Genome Institute, Washington University
Zachary L SkidmoreMcDonnell Genome Institute, Washington University
Matthew J ChristopherWashington University
Jeffery M KlcoSt. Jude Children's Research Hospital
Avinash RamuMcDonnell Genome Institute, Washington University
Avinash RamuMcDonnell Genome Institute, Washington University
Tamara L LamprechtSt. Jude Children's Research Hospital
Alex H WagnerMcDonnell Genome Institute, Washington University
Katie M CampbellMcDonnell Genome Institute, Washington University
Robert LesurfMcDonnell Genome Institute, Washington University
Jasreet HundalMcDonnell Genome Institute, Washington University
Jin ZhangMcDonnell Genome Institute, Washington University
Nicholas C SpiesMcDonnell Genome Institute, Washington University
Benjamin J AinscoughMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
David E LarsonMcDonnell Genome Institute, Washington University
Sharon E HeathWashington University
Catrina FronickMcDonnell Genome Institute, Washington University
Michelle O'LaughlinMcDonnell Genome Institute, Washington University
Robert S FultonMcDonnell Genome Institute, Washington University
Robert S FultonMcDonnell Genome Institute, Washington University
Vincent MagriniMcDonnell Genome Institute, Washington University
Sean McGrathMcDonnell Genome Institute, Washington University
Scott M SmithMcDonnell Genome Institute, Washington University
Christopher A MillerMcDonnell Genome Institute, Washington University
Christopher A MaherMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
Christopher A MaherMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
Jacqueline E PaytonSiteman Cancer Center, Washington University
Jason WalkerMcDonnell Genome Institute, Washington University
James M EldredMcDonnell Genome Institute, Washington University
Matthew J WalterSiteman Cancer Center, Washington University
Daniel C LinkSiteman Cancer Center, Washington University
Timothy A GraubertMassachusetts General Hospital Cancer Center
Peter WesterveltSiteman Cancer Center, Washington University
Shashikant KulkarniWashington University
John F DiPersioSiteman Cancer Center, Washington University
Elaine R MardisMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
Elaine R MardisMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
Richard K WilsonMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
Richard K WilsonMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
Timothy J LeyMcDonnell Genome Institute, Washington University, USA Siteman Cancer Center
  • 1 - 42

Datasets